Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP842221.RAI84TIpzOVcGjpzNdY_zxvUryUSPbKksDcCh9r-wm-XY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP842221.RAI84TIpzOVcGjpzNdY_zxvUryUSPbKksDcCh9r-wm-XY130_assertion type Assertion NP842221.RAI84TIpzOVcGjpzNdY_zxvUryUSPbKksDcCh9r-wm-XY130_head.
- NP842221.RAI84TIpzOVcGjpzNdY_zxvUryUSPbKksDcCh9r-wm-XY130_assertion description "[They included HOXA4 and HOXA7 because, by cDNA microarray analysis, these were more highly expressed in invasive ovarian carcinomas than in benign or borderline (noninvasive) ovarian tumors, and HOXA9 because it characterizes normal oviductal epithelium, which resembles ovarian serous adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842221.RAI84TIpzOVcGjpzNdY_zxvUryUSPbKksDcCh9r-wm-XY130_provenance.
- NP842221.RAI84TIpzOVcGjpzNdY_zxvUryUSPbKksDcCh9r-wm-XY130_assertion evidence source_evidence_literature NP842221.RAI84TIpzOVcGjpzNdY_zxvUryUSPbKksDcCh9r-wm-XY130_provenance.
- NP842221.RAI84TIpzOVcGjpzNdY_zxvUryUSPbKksDcCh9r-wm-XY130_assertion SIO_000772 19281776 NP842221.RAI84TIpzOVcGjpzNdY_zxvUryUSPbKksDcCh9r-wm-XY130_provenance.
- NP842221.RAI84TIpzOVcGjpzNdY_zxvUryUSPbKksDcCh9r-wm-XY130_assertion wasDerivedFrom befree-20140225 NP842221.RAI84TIpzOVcGjpzNdY_zxvUryUSPbKksDcCh9r-wm-XY130_provenance.
- NP842221.RAI84TIpzOVcGjpzNdY_zxvUryUSPbKksDcCh9r-wm-XY130_assertion wasGeneratedBy ECO_0000203 NP842221.RAI84TIpzOVcGjpzNdY_zxvUryUSPbKksDcCh9r-wm-XY130_provenance.